S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

May 31, 2012

Study Completion Date

November 30, 2015

Conditions
Multiple MyelomaPlasma Cell Myeloma
Interventions
BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

dexamethasone

DRUG

melphalan

DRUG

thalidomide

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (35)

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

37916

Thompson Cancer Survival Center, Knoxville

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

48202

Josephine Ford Cancer Center at Henry Ford Hospital, Detroit

59101

CCOP - Montana Cancer Consortium, Billings

Hematology-Oncology Centers of the Northern Rockies - Billings, Billings

Northern Rockies Radiation Oncology Center, Billings

59405

Great Falls Clinic - Main Facility, Great Falls

Sletten Cancer Institute at Benefis Healthcare, Great Falls

Great Falls

59501

Northern Montana Hospital, Havre

59601

St. Peter's Hospital, Helena

59701

St. James Healthcare Cancer Care, Butte

59715

Bozeman Deaconess Cancer Center, Bozeman

59804

Guardian Oncology and Center for Wellness, Missoula

59807

Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula

59901

Glacier Oncology, PLLC, Kalispell

Kalispell Medical Oncology at KRMC, Kalispell

67401

Tammy Walker Cancer Center at Salina Regional Health Center, Salina

72205

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock

82609

Rocky Mountain Oncology, Casper

82801

Welch Cancer Center at Sheridan Memorial Hospital, Sheridan

83712

Mountain States Tumor Institute at St. Luke's Regional Medical Center, Boise

95817

University of California Davis Cancer Center, Sacramento

97210

Legacy Good Samaritan Hospital & Comprehensive Cancer Center, Portland

97227

Northwest Cancer Specialists at Rose Quarter Cancer Center, Portland

98109

Fred Hutchinson Cancer Research Center, Seattle

98195

University Cancer Center at University of Washington Medical Center, Seattle

66160-7357

Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City

02118

Boston University Cancer Research Center, Boston

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

59107-7000

Billings Clinic - Downtown, Billings

59405-5309

Big Sky Oncology, Great Falls

59807-7877

Montana Cancer Specialists at Montana Cancer Center, Missoula

98122-4307

Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK

NCT00064337 - S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis | Biotech Hunter | Biotech Hunter